Even though absence of CD44 strongly disrupted glioma invasion in brain slices and in vitro, cell invasion from DKO11804 and GL261-derived tumors was only mildly affected in myeloid CD44-deficient syngeneic hosts, despite the significant differences of both cell lines in respect to tumor growth and infiltration of the surrounding tissue. Here, CD44 is linked to central nervous system cancer.